tiprankstipranks
Trending News
More News >
Tourmaline Bio announces results from ongoing Phase 2 TRANQUILITY trial
PremiumThe FlyTourmaline Bio announces results from ongoing Phase 2 TRANQUILITY trial
18d ago
Buy Rating for Tourmaline Bio: Anticipated Catalyst from Phase 2 TRANQUILITY Study on Pacibekitug
Premium
Ratings
Buy Rating for Tourmaline Bio: Anticipated Catalyst from Phase 2 TRANQUILITY Study on Pacibekitug
25d ago
Tourmaline Bio’s Pacibekitug: A Promising IL-6 Inhibitor for ASCVD with Strong Buy Rating
Premium
Ratings
Tourmaline Bio’s Pacibekitug: A Promising IL-6 Inhibitor for ASCVD with Strong Buy Rating
26d ago
Positive Buy Rating for Tourmaline Bio Driven by Promising Pacibekitug Developments and Strategic Value
PremiumRatingsPositive Buy Rating for Tourmaline Bio Driven by Promising Pacibekitug Developments and Strategic Value
3M ago
Tourmaline Bio price target raised to $43 from $42 at Wedbush
Premium
The Fly
Tourmaline Bio price target raised to $43 from $42 at Wedbush
3M ago
Buy Rating for Tourmaline Bio: Potential of Pacibekitug and Upcoming CKD Data Release
Premium
Ratings
Buy Rating for Tourmaline Bio: Potential of Pacibekitug and Upcoming CKD Data Release
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100